NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Operating income, 2025
- $619M
- YoY, 2025
- +8.5%
- 5-year CAGR
- +30.6%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $619M | +8.5% |
| 2024 | $571M | +127.4% |
| 2023 | $251M | +0.8% |
| 2022 | $249M | +142.9% |
| 2021 | $103M | −37.1% |
| 2020 | $163M | +125.4% |
| 2019 | $72M | +96.5% |
| 2018 | $37M | — |
| 2017 | −$131M | — |
| 2016 | −$147M | — |
| 2015 | −$94M | — |
| 2014 | −$64M | — |
| 2013 | −$50M | — |
| 2012 | $1.4M | −95.7% |
| 2011 | $34M | — |
| 2010 | −$14M | — |
| 2009 | −$54M | — |